B.Tech

Zydus Biologics or Zydus Healthcare Limited (also known as Zydus Cadila) is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat, India primarily engaged in the manufacture of generic drugs. It ranked 100th in the Fortune India 500 list in 2020. Cadila was founded in 1952 by Ramanbhai Patel (19252001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Indravadan Modi. It evolved over the next four decades into an established pharmaceutical company.

Endo India Par Formulations is o pharmaceutical company that develops, manufacturers and markets safe, innovative and cost-effective pharmaceuticals that help improve patient quality of life. At Endo our Investment in state-of-the-art equipment and facilities, commitment to ethical standards, and growing portfolio of products makes us a company where you can enjoy a productive career with long-term potential.

Every successful strategy is supported by high-quality research. And this is what BrandEssence® Market Research lives on. We provide in-depth and pertinent industry reports from around every domain and industries worldwide. Our analysts draw on economic, demographic, and market information to support organisations in making the best business decisions. BrandEssence® Market Research has been providing industry information since 2017.

Post : Research Associate

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

NIAB invites applications for admission to its PhD program from highly motivated students for the 2022 session. NIAB is an autonomous institution of the Department of Biotechnology (DBT), Government of India, leading in basic and translational research on animal health and productivity and human-animal interface with a motto to improve animal health for human welfare. The institute has a ravishing 100–acre campus in Gachibowli, Hyderabad.

Syngene International Ltd is an integrated research, development and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. Syngene’s 4500+ scientists offer both skills and the capacity to deliver great science, robust data management and IP security and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.

Genei are harnessing cutting-edge technology in the space of MDx, in order to solve complex diagnostic challenges. Genei Laboratories Pvt. Ltd. develops and produces an array of high-quality, affordable life science products. Genei addresses your molecular biology, protein science reagent needs, along with kits for teaching and diagnostics. It also provides a variety of custom services in the field of biology. We also provide products from other producers, both international and domestic.

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

CSIR-Central Drug Research Institute, Lucknow, a premier Institute under Council of Scientific and Industrial Research (CSIR), is involved in multidisciplinary R&D programs of both basic and applied nature. CSIR-CDRI is a pioneer biomedical research organization in India and has the infrastructure and expertise to develop a drug from concept to commercialization. In the year 2012, CSIR-CDRI shifted to its state of the art new campus, which has been set up with a vision to serve as a Nodal Center of CSIR in new drug discovery and development.